prenylflavonoids

Developed for: postmenopausal atrophic vaginitis
Investigated by: University of Athens · University of Messina · University of Victoria

today NCT03281655 · Ph 2

20172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT03281655	Dec 2016 → May 2017	postmenopausal atrophic vaginitis	University of Messina	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	prenylflavonoids	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03281655 ↗
Action	Activate	“prenylflavonoids and phytoestrogens play a potent role as estrogen receptor (ER)-alpha selective agonist” NCT03281655 ↗